BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 27788764)

  • 1. Haploidentical cord transplantation-The best of both worlds.
    van Besien K; Childs R
    Semin Hematol; 2016 Oct; 53(4):257-266. PubMed ID: 27788764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts.
    Raiola AM; Dominietto A; di Grazia C; Lamparelli T; Gualandi F; Ibatici A; Bregante S; Van Lint MT; Varaldo R; Ghiso A; Gobbi M; Carella AM; Signori A; Galaverna F; Bacigalupo A
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1573-9. PubMed ID: 24910379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.
    van Besien K; Hari P; Zhang MJ; Liu HT; Stock W; Godley L; Odenike O; Larson R; Bishop M; Wickrema A; Gergis U; Mayer S; Shore T; Tsai S; Rhodes J; Cushing MM; Korman S; Artz A
    Haematologica; 2016 May; 101(5):634-43. PubMed ID: 26869630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning.
    Tsai SB; Liu H; Shore T; Fan Y; Bishop M; Cushing MM; Gergis U; Godley L; Kline J; Larson RA; Martinez G; Mayer S; Odenike O; Stock W; Wickrema A; van Besien K; Artz AS
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):1065-1072. PubMed ID: 26912055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unrelated cord blood compared with haploidentical grafts in patients with hematological malignancies.
    El-Cheikh J; Crocchiolo R; Furst S; Bramanti S; Sarina B; Granata A; Vai A; Lemarie C; Faucher C; Mohty B; Harbi S; Bouabdallah R; Vey N; Santoro A; Chabannon C; Castagna L; Blaise D
    Cancer; 2015 Jun; 121(11):1809-16. PubMed ID: 25649994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cord blood chimerism and relapse after haplo-cord transplantation.
    van Besien K; Koshy N; Gergis U; Mayer S; Cushing M; Rennert H; Reich-Slotky R; Mark T; Pearse R; Rossi A; Phillips A; Vasovic L; Ferrante R; Hsu YM; Shore T
    Leuk Lymphoma; 2017 Feb; 58(2):288-297. PubMed ID: 27333804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritransplantation Glucocorticoid Haploidentical Stem Cell Transplantation Is a Promising Strategy for AML Patients With High Leukemic Burden: Comparison With Transplantations Using Other Donor Types.
    Kaida K; Ikegame K; Inoue T; Maruyama S; Ishii S; Uchida N; Doki N; Eto T; Fukuda T; Katayama Y; Takada S; Kawakita T; Ichinohe T; Atsuta Y; Daimon T; Ogawa H
    Transplant Cell Ther; 2023 Apr; 29(4):273.e1-273.e9. PubMed ID: 36641032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced-Intensity Allogeneic Transplant for Acute Myeloid Leukemia and Myelodysplastic Syndrome Using Combined CD34-Selected Haploidentical Graft and a Single Umbilical Cord Unit Compared with Matched Unrelated Donor Stem Cells in Older Adults.
    Tsai SB; Rhodes J; Liu H; Shore T; Bishop M; Cushing MM; Gergis U; Godley L; Kline J; Larson RA; Mayer S; Odenike O; Stock W; Wickrema A; van Besien K; Artz AS
    Biol Blood Marrow Transplant; 2018 May; 24(5):997-1004. PubMed ID: 29288821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors.
    Solomon SR; Sizemore CA; Sanacore M; Zhang X; Brown S; Holland HK; Morris LE; Bashey A
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1299-307. PubMed ID: 25797174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic Leukemia.
    Hsu J; Artz A; Mayer SA; Guarner D; Bishop MR; Reich-Slotky R; Smith SM; Greenberg J; Kline J; Ferrante R; Phillips AA; Gergis U; Liu H; Stock W; Cushing M; Shore TB; van Besien K
    Biol Blood Marrow Transplant; 2018 Feb; 24(2):359-365. PubMed ID: 29128555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined haploidentical and cord blood transplantation for refractory severe aplastic anaemia and hypoplastic myelodysplastic syndrome.
    Childs RW; Tian X; Vo P; Purev E; Kotecha RR; Carlsten M; Clara J; Flegel WA; Adams SD; Khuu HM; Stroncek DF; Cook L; Worthy T; Geller NL; Wells B; Wilder J; Reger R; Aue G
    Br J Haematol; 2021 Jun; 193(5):951-960. PubMed ID: 33993466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation.
    Gaballa S; Ge I; El Fakih R; Brammer JE; Kongtim P; Tomuleasa C; Wang SA; Lee D; Petropoulos D; Cao K; Rondon G; Chen J; Hammerstrom A; Lombardi L; Alatrash G; Korbling M; Oran B; Kebriaei P; Ahmed S; Shah N; Rezvani K; Marin D; Bashir Q; Alousi A; Nieto Y; Qazilbash M; Hosing C; Popat U; Shpall EJ; Khouri I; Champlin RE; Ciurea SO
    Cancer; 2016 Nov; 122(21):3316-3326. PubMed ID: 27404668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single Cord Blood Transplantation Versus HLA-Haploidentical-related Donor Transplantation Using Posttransplant Cyclophosphamide in Patients With Hematological Malignancies.
    Wada F; Kanda J; Yoshioka S; Ishikawa T; Akasaka T; Ueda Y; Hirata H; Arai Y; Yago K; Anzai N; Watanabe M; Ikeda T; Yonezawa A; Imada K; Itoh M; Kitano T; Takeoka T; Hishizawa M; Nohgawa M; Arima N; Asagoe K; Kondo T; Takaori-Kondo A;
    Transplantation; 2022 Jun; 106(6):1279-1287. PubMed ID: 34935764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults.
    van Heeckeren WJ; Fanning LR; Meyerson HJ; Fu P; Lazarus HM; Cooper BW; Tse WW; Kindwall-Keller TL; Jaroscak J; Finney MR; Fox RM; Solchaga L; Forster M; Creger RJ; Laughlin MJ
    Br J Haematol; 2007 Nov; 139(3):464-74. PubMed ID: 17910637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative donor transplantation--"mixing and matching": the role of combined cord blood and haplo-identical donor transplantation (haplo-cord SCT) as a treatment strategy for patients lacking standard donors?
    Liu H; van Besien K
    Curr Hematol Malig Rep; 2015 Mar; 10(1):1-7. PubMed ID: 25667129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective Randomized Study Comparing Myeloablative Unrelated Umbilical Cord Blood Transplantation versus HLA-Haploidentical Related Stem Cell Transplantation for Adults with Hematologic Malignancies.
    Sanz J; Montoro J; Solano C; Valcárcel D; Sampol A; Ferrá C; Parody R; Lorenzo I; Montesinos P; Ortí G; Hernández-Boluda JC; Balaguer-Roselló A; Guerreiro M; Carretero C; Sanz GF; Sanz MA; Piñana JL
    Biol Blood Marrow Transplant; 2020 Feb; 26(2):358-366. PubMed ID: 31655119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential Transplantation of Haploidentical Stem Cell and Unrelated Cord Blood With Using ATG/PTCY Increases Survival of Relapsed/Refractory Hematologic Malignancies.
    Li H; Li X; Chen Y; Li D; Chen X; Zhu Z; Wang Y; Huang J; Chen P; Chen Y; Li N
    Front Immunol; 2021; 12():733326. PubMed ID: 34804017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haplo-cord transplantation using CD34+ cells from a third-party donor to speed engraftment in high-risk patients with hematologic disorders.
    Kwon M; Bautista G; Balsalobre P; Sánchez-Ortega I; Serrano D; Anguita J; Buño I; Fores R; Regidor C; García Marco JA; Vilches C; de Pablo R; Fernández MN; Gayoso J; Duarte R; Díez-Martín JL; Cabrera R
    Biol Blood Marrow Transplant; 2014 Dec; 20(12):2015-22. PubMed ID: 25255162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Haploidentical donor peripheral blood stem cell transplantation using third-party cord blood compared with matched unrelated donor transplantation for patients with hematologic malignancies].
    Ma X; Chen Y; Liu Y; Cheng TT; Chen X; Zeng C; Hua J; Wang SY; Xu YJ
    Zhonghua Xue Ye Xue Za Zhi; 2024 Feb; 45(2):141-147. PubMed ID: 38604790
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of Haploidentical Hematopoietic Stem Cell Transplant With or Without Unrelated Cord Blood Infusion in Severe Aplastic Anemia: Outcomes of a Multicenter Study.
    Lei M; Zhang Y; Jiao W; Li X; Zhou H; Wang Q; Qiu H; Tang X; Han Y; Fu C; Jin Z; Chen S; Sun A; Miao M; Liu L; Wu D
    Front Immunol; 2022; 13():912917. PubMed ID: 35812409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.